Pliant Therapeutics Inc (PLRX) — Financial Flexibility Index
Pliant Therapeutics Inc (PLRX) has a Financial Flexibility Index of -0.30x as of June 2026. Free cash flow of $-12.80 Million (operating CF $-12.80 Million minus capex $0.00) represents 0% of total liabilities ($42.95 Million). Check cash flow reinvestment rate of Pliant Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pliant Therapeutics Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Pliant Therapeutics Inc across 9 annual periods. For the full cash flow conversion analysis, see PLRX cash generation efficiency.
Annual Financial Flexibility Index for Pliant Therapeutics Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Pliant Therapeutics Inc. Explore PLRX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.91x | $-127.96 Million | $-128.34 Million | $44.02 Million | ▼ -78.0% |
| 2024 | -1.63x | $-151.66 Million | $-155.50 Million | $92.87 Million | ▲ +45.4% |
| 2023 | -2.99x | $-115.44 Million | $-116.36 Million | $38.58 Million | ▼ -20.1% |
| 2022 | -2.49x | $-92.87 Million | $-94.63 Million | $37.27 Million | ▲ +24.9% |
| 2021 | -3.32x | $-73.49 Million | $-75.44 Million | $22.16 Million | ▼ -15.7% |
| 2020 | -2.87x | $-35.74 Million | $-37.27 Million | $12.46 Million | ▼ -19083.7% |
| 2019 | -0.01x | $-1.79 Million | $-2.75 Million | $119.50 Million | ▲ +96.1% |
| 2018 | -0.39x | $-26.00 Million | $-28.33 Million | $67.41 Million | ▲ +92.1% |
| 2017 | -4.87x | $-15.52 Million | $-16.92 Million | $3.19 Million | — |